#United States #New York #Organon Co #XOMA Royalty #Helix Energy Solutions

Shareholder Alert: Major Mergers Under Investigation

In recent developments, class action attorney Juan Monteverde from Monteverde & Associates PC has announced investigations into several major mergers involving publicly traded companies, namely Helix Energy Solutions Group, Organon Co., XOMA Royalty Corporation, and RE/MAX Holdings, Inc. These inquiries come amidst corresponding efforts to protect the rights and financial interests of shareholders affected by these significant transactions.

Helix Energy Solutions Group and Hornbeck Offshore Services Merger

The first of the highlighted cases involves Helix Energy Solutions Group Inc. (NYSE: HLX) and its proposed merger with Hornbeck Offshore Services Inc. This transaction is expected to yield a combined enterprise where Helix shareholders would hold approximately 45% on a fully diluted basis. Concerns have arisen over the terms of this merger, leading to scrutiny by Monteverde & Associates. Shareholders who wish to inquire further into the potential ramifications of this merger are encouraged to visit Monteverde's Helix Case Page.

Organon Co. and Sun Pharmaceuticals Sale

The second investigation focuses on Organon Co. (NYSE: OGN), which is in talks over its impending sale to Sun Pharmaceuticals Industries Limited. As per the proposed deal, Organon shareholders are set to receive $14.00 per share in cash. While this offer may seem attractive, shareholders must consider whether this transaction fully reflects the company's market value. Monteverde encourages affected shareholders to assess their positions on this significant transition by reviewing additional information found at Monteverde's Organon Case Page.

XOMA Royalty Corporation's Sale to Ligand Pharmaceuticals

The third inquiry pertains to XOMA Royalty Corporation (NASDAQ: XOMA) and its proposed acquisition by Ligand Pharmaceuticals Incorporated. Shareholders in XOMA stand to receive $39.00 per share in cash under the terms of this transaction. However, as with the previous investigations, shareholders are advised to weigh their options carefully. For more details, interested shareholders should check out Monteverde's XOMA Case Page.

RE/MAX Holdings, Inc. and The Real Brokerage Inc.

Lastly, RE/MAX Holdings, Inc. (NYSE: RMAX) is also featured in the investigation concerning its sale to The Real Brokerage Inc. Shareholders of RE/MAX are expected to receive either 5.152 shares of the new entity or $13.80 in cash per share. This dual-option offer has raised questions regarding equity and fairness to all parties involved. For affected RE/MAX shareholders seeking clarity, details can be found on Monteverde's RE/MAX Case Page.

Seeking Justice for Shareholders

Monteverde & Associates PC asserts that not all law firms are equally equipped to advocate for shareholders, stressing the importance of understanding the credentials and successes of any legal representation before proceeding. With a track record of recovering millions for shareholders and a reputation solidified by the 2025 ISS Securities Class Action Services Report ranking Monteverde as a Top 50 Firm, stakeholders are urged to seek out seasoned counsel for their concerns surrounding these significant mergers.

As the landscape of public company mergers evolves, shareholders must remain vigilant. If you own stock in one of the companies listed and are concerned about how these transactions may impact your investments, do not hesitate to contact Juan Monteverde, Esq., via email at [email protected] or at (212) 971-1341 for more information.